Form 4: Nuvalent Director Matthew Shair Sells Shares Under 10b5-1 Trading Plan

Director Matthew Shair of Nuvalent, Inc. executed multiple sales of Class A Common Stock on January 27, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On January 27, 2025, Matthew Shair, a director of Nuvalent, Inc., sold shares of Class A Common Stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on December 21, 2023.
• Multiple transactions occurred at varying prices, ranging from $81.57 to $85.48 per share.
• A total of 1,040 shares were sold at a weighted average price of $82.24.
• An additional 618 shares were sold at a weighted average price of $82.91.
• Another 234 shares were sold at a weighted average price of $83.88.
• Finally, 108 shares were sold at a weighted average price of $85.
• Following these transactions, Mr. Shair directly owns 1,427,197 shares and indirectly owns 218,522 shares through the Matthew D. Shair 2021 Irrevocable Family Trust.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The sentiment is neutral as it simply reports the sale of shares under a pre-existing trading plan.

Industry Context

Sales by insiders are a common occurrence and are often related to personal financial planning. The use of a 10b5-1 trading plan allows insiders to sell shares at predetermined times and prices, avoiding accusations of trading on inside information.

Stakeholder Impact

• The sale of shares by a director could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates